University of Vermont — Burlington, Vermont

University of Vermont is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Vermont has participated in 205 clinical trials with 41 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Ocular Myasthenia Gravis.

Sponsors: Regeneron Pharmaceuticals, Michael Benatar, National Center for Complementary and Integrative Health (NCCIH).

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Vermont?

University of Vermont has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Vermont conducted?

University of Vermont has 205 clinical trials on record, with 41 currently active. Their work covers Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Ocular Myasthenia Gravis.

Is University of Vermont accredited by Crixeo Health?

University of Vermont has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Vermont?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.